Cite
HARVARD Citation
Trucco, M. et al. (2018). A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG‐asparaginase, and doxorubicin. Pediatric blood & cancer. 65 (9), p. n/a. [Online].